SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001664767-20-000001
Filing Date
2020-08-21
Accepted
2020-08-21 13:43:20
Documents
1
Effectiveness Date
2020-08-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11584
  Complete submission text file 0001664767-20-000001.txt   12629
Mailing Address 2820-200 GRANVILLE STREET VANCOUVER A1 BC V6C 1S4
Business Address 2820-200 GRANVILLE STREET VANCOUVER A1 BC V6C 1S4 (604) 336-7906
Aequus Pharmaceuticals Inc. (Filer) CIK: 0001664767 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-373814 | Film No.: 201122772